Pharma and healthcare funds have become popular among investors looking to benefit from the long-term growth of India’s pharmaceutical, hospital, and diagnostics sectors. These funds invest in companies involved in medicines, healthcare services, medical equipment, and laboratories.
In 2026, the healthcare sector continues to attract investor interest due to rising healthcare spending, ageing populations, and stronger demand for medicines and diagnostics. However, pharma funds are sectoral funds, which means they can be more volatile than diversified equity funds.
Why Pharma Mutual Funds India Are Gaining Attention
The category of Pharma Mutual Funds India has seen strong growth because many investors want focused exposure to healthcare-related companies instead of investing in individual pharma stocks.
Sector healthcare mutual funds have reported healthy inflows and rising assets under management in 2026. Funds such as the SBI Healthcare Opportunities Fund and WhiteOak Capital Pharma and Healthcare Fund have seen notable growth in investor interest this year.
Some reasons why investors are considering these funds include:
- Growing demand for healthcare and medicines
- Expansion of hospitals and diagnostics businesses
- Lower risk compared to buying one pharma stock directly
- Opportunity to benefit from long-term sector growth
Best Pharma Mutual Funds India in 2026
Here are some of the leading healthcare and pharma-focused mutual funds in India based on assets, long-term returns, and popularity:
| Fund | Approx. AUM | 3-Year Return |
| Nippon India Pharma Fund | ₹8,357 crore | 22% |
| ICICI Prudential Pharma Healthcare & Diagnostics Fund | ₹6,801 crore | 28% |
| SBI Healthcare Opportunities Fund | ₹4,077 crore | 26% |
| UTI Healthcare Fund | ₹1,097 crore | 25% |
| DSP Healthcare Fund | ₹3,107 crore | 24% |
These funds have remained among the most watched options in the healthcare category because of their exposure to companies such as Sun Pharmaceutical Industries, Cipla, Divi’s Laboratories, and Apollo Hospitals.
Who Should Invest in Pharma Mutual Funds India
Pharma Mutual Funds India are suitable for investors who:
- Already have a diversified portfolio
- Want additional exposure to the healthcare sector
- Can stay invested for at least 5 years
- Are comfortable with higher risk and short-term volatility
Because these are sectoral funds, experts usually suggest limiting them to a smaller portion of your portfolio rather than making them your only investment.
Risks to Consider Before Investing
Although the healthcare sector has strong long-term potential, pharma mutual funds can be affected by:
- Government regulations
- Changes in medicine pricing
- Export restrictions
- Slowdowns in healthcare demand
- Sharp movements in pharma company share prices
These funds are considered “very high risk” and may perform differently from the overall stock market.
How Mutual Fund Screener Helps Investors
Mutual Fund Screener aims to make investing easier by explaining complex mutual fund topics in simple language. Instead of using difficult financial terms, the platform helps beginners understand fund categories, market trends, and sector opportunities like pharma funds.
For investors researching Pharma Mutual Funds India, platforms such as Mutual Fund Screener can help compare returns, risk, and portfolio composition before making an investment decision.
Final Thoughts on Pharma Mutual Funds India
Pharma Mutual Funds India can be a good option for investors who want focused exposure to one of India’s fastest-growing sectors. Funds such as ICICI Prudential Pharma Healthcare & Diagnostics Fund and Nippon India Pharma Fund continue to remain among the top choices due to their strong track record and growing assets.
However, since these are sector-specific funds, it is important to invest carefully, stay invested for the long term, and ensure they fit your overall financial goals.
Frequently Asked Questions
What are Pharma Mutual Funds India?
Pharma Mutual Funds India are sectoral mutual funds that invest mainly in pharmaceutical, healthcare, hospital, and diagnostics companies. These funds aim to benefit from the long-term growth of the healthcare sector.
Are pharma mutual funds a good investment in 2026?
Pharma funds can be a good investment in 2026 for investors who believe in the future growth of the healthcare sector. However, since they are sector-specific funds, they carry higher risk than diversified equity funds.
How long should I stay invested in pharma mutual funds?
Experts generally recommend staying invested in pharma mutual funds for at least 5 years. This gives the fund enough time to benefit from long-term growth trends in the healthcare and pharmaceutical sectors.
Which are the top pharma mutual funds in India?
Some of the leading pharma and healthcare mutual funds in India include:
- Nippon India Mutual Fund – Nippon India Pharma Fund
- ICICI Prudential Mutual Fund – ICICI Prudential Pharma Healthcare & Diagnostics Fund
- SBI Mutual Fund – SBI Healthcare Opportunities Fund
- UTI Mutual Fund – UTI Healthcare Fund
- DSP Mutual Fund – DSP Healthcare Fund
Are Pharma Mutual Funds India risky?
Yes, Pharma Mutual Funds India are considered high-risk because they depend on the performance of a single sector. Changes in government policies, drug pricing, exports, or healthcare demand can affect their returns.
Can beginners invest in pharma mutual funds?
Beginners can invest in pharma mutual funds, but only after building a diversified portfolio first. Sectoral funds are usually better suited for investors who already have experience and understand market risks.
What is the minimum amount required to invest?
Most mutual funds allow SIP investments starting from ₹500 per month, while lump-sum investments can often begin from ₹1,000 to ₹5,000 depending on the fund.